Skip to main content

Nanosphere Licenses Protein Detection Technology from Northwestern University

NEW YORK, Oct. 8 (GenomeWeb News) – Chicago-based Nanosphere today announced that it has licensed a detection technology for protein analytes from Northwestern University.

The technology was developed by Nanosphere co-founder and Northwestern University professor Chad Merkin and described in the Sept. 26 issue of Science .

Financial details of the licensing deal were not disclosed.

The method is based on magnetic microparticle probes with antibodies that specifically bind a target of interest and nanoparticle probes that are encoded with DNA that is unique to the protein target of interest and antibodies that can sandwich the target captured by the probes, the article says.

The technology was first applied to detecting prostate specific antigen.

The company said it plans to combine the technology with its detection systems for DNA.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.